This inventor holds 3 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2010-2013.
Company Filing History:
Years Active: 2010-2013
Title: Joseph M Langenhan: Innovator in Chemical Glycosylation
Introduction
Joseph M Langenhan is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of chemical glycosylation, focusing on the development of compounds with enhanced properties and reduced side effects. With a total of 3 patents to his name, Langenhan's work is paving the way for advancements in cancer treatment.
Latest Patents
Langenhan's latest patents include innovative methods for producing libraries of compounds that exhibit desirable properties while minimizing adverse effects. His work on neoglycorandomization and digitoxin analogs highlights a universal chemical glycosylation method that utilizes reducing sugars without the need for protection or activation. This method has led to the creation of neoglycoside digitoxin analogs that demonstrate significantly enhanced cytotoxic potency against human cancer cells, while also being less potent Na/K-ATPase inhibitors compared to digitoxin.
Career Highlights
Joseph M Langenhan is associated with the Wisconsin Alumni Research Foundation, where he continues to explore and develop his innovative ideas. His research has the potential to revolutionize the way compounds are synthesized and utilized in medical applications.
Collaborations
Langenhan collaborates with Jon Scott Thorson, further enhancing the scope and impact of his research endeavors.
Conclusion
Joseph M Langenhan's contributions to the field of chemical glycosylation and his innovative patents are significant steps forward in the quest for effective cancer treatments. His work exemplifies the importance of innovation in the medical field.